Mesenchymal stem cells for graft-versus-host disease: a double edged sword?
Vianello
F
F
Dazzi
F
F
D000328:Adult; D002648:Child; D017321:Clinical Trials, Phase I as Topic / Q000706:statistics & numerical data; D005260:Female; D005347:Fibroblasts / Q000502:physiology; D006086:Graft vs Host Disease / Q000517:prevention & control*; D020544:Graft vs Leukemia Effect; D019337:Hematologic Neoplasms / Q000601:surgery*; D006801:Humans; D007165:Immunosuppression Therapy; D017053:Infection Control; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation / Q000009:adverse effects*; D014411:Neoplastic Stem Cells / Q000502:physiology; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012008:Recurrence; D014184:Transplantation, Homologous